Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors

被引:3
|
作者
Atilla, Aynur [1 ]
Celik, Merve [1 ]
Colak, Ozkul Yilmaz [2 ]
Kuruoglu, Tuba [1 ]
Temocin, Fatih [1 ]
Kelkitli, Engin [2 ]
Birinci, Asuman [3 ]
机构
[1] Ondokuz Mayis Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Samsun, Turkey
[2] Ondokuz Mayis Univ, Div Hematol, Fac Med, Samsun, Turkey
[3] Ondokuz Mayis Univ, Dept Med Microbiol, Fac Med, Samsun, Turkey
来源
MIKROBIYOLOJI BULTENI | 2022年 / 56卷 / 02期
关键词
Invasive fungal infections; hematological malignancies; molds; construction; renovation; NOSOCOMIAL FUNGAL-INFECTIONS; EPIDEMIOLOGY; DISEASE; RISK; ASPERGILLOSIS;
D O I
10.5578/mb.20229810
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive fungal infections (IFI) continue to be an important cause of morbidity and mortality in patients with hematological malignancies. Candida and Aspergillus species constitute most of the IFI in these patients.. It has been reported that most of the invasive aspergillosis epidemics are related to the construction works in the hospital. In this study, we aimed to investigate the frequency of IFI in the old and the new hospital building after relocation in patients with hematological malignancies. Of 8042 patients who were hospitalized in the Department of Hematology, Ondokuz Mayis University Faculty of Medicine between January 2015 and September 2019, 412 patients who were initiated antifungal therapy were included in the study. The patients in the hematology clinic, which were moved to the new oncology hospital building in January 2018, were grouped as prior and after relocation, and their demographical data, hematological diagnosis, chemotherapy regimens, mortality, IFI, focus of infection, presence of central venous catheter, antifungal prophylaxis and treatment, galactomannan level, fungal culture and computed tomography (CT) findings were evaluated retrospectively. It was determined that 55% of the patients were male and the median age was 58 (range:18-93). The rate of IFI development was 5.12% (n= 412) and the rate of invasive mold infection was 1.2% (n= 145). The most common hematological disease for which antifungal treatment initiated was acute myeloid leukemia (AML) with a rate of 50% (n= 206/412). Of patients, 73% received induction chemotherapy (42%, first induction, 31% reinduction), 13.4% received consolidation therapy. Invasive mold infection was diagnosed as 40% possible, 59% probable, 1% proven. While patients had similar characteristics such as age, gender, hematological disease, chemotherapy regimens and antifungal prophylaxis prior and after transportation, the rate of development of invasive mold infection was 2.1%, 2.06 / 1000 patient days, before transportation, 1.37% (p= 0.009), 1.15/1000 patient days (p< 0.001) after transportation, and it was statistically significantly lower after transportation. The median value of galactomannan antigen was detected as 0.17 (0.02-5.9). Blood cultures revealed 10.3% fungal growth and the most common growth was Candida albicans with 54.8% and Mucor spp. as mold with 3.2%. Large-scale construction works such as renovation, extension and demolition works in old hospital buildings are a permanent condition in different units. Clinicians should be aware of that infections due to opportunistic fungi can be seen in immunosuppressive patients close to such construction sites, and even cause epidemics. It should be kept in mind that these infections, which can progress with serious morbidity and mortality are difficult to treat but can be prevented by infection control measures.
引用
收藏
页码:315 / 325
页数:11
相关论文
共 50 条
  • [1] Breakthrough Invasive Mold Infections in Hematologic Cases: Relevance of the Host's Factors
    Rodriguez-Goncer, Isabel
    Boan, Jorge
    Carrero-Arribas, Riansares
    Sanchez-Pina, Jose Maria
    Lizasoain, Manuel
    Fernandez-Ruiz, Mario
    San-Juan, Rafael
    Lopez-Medrano, Francisco
    Perez-Ayala, Ana
    Caro-Teller, Jose Manuel
    Martinez-Lopez, Joaquin
    Aguado, Jose Maria
    Calbacho, Maria
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (02):
  • [2] Invasive fungal infections in hematologic patients
    Lopez, F
    Jarque, I
    Martin, G
    Sanz, GF
    Palau, J
    Martinez, J
    de la Rubia, J
    Larrea, L
    Arnao, M
    Solves, P
    Cervera, J
    Martinez, ML
    Peman, J
    Gobernado, M
    Sanz, MA
    MEDICINA CLINICA, 1998, 110 (11): : 401 - 405
  • [3] Antifungal Prophylaxis and Risk for Invasive Mold Infections in Children with Hematologic Malignancies
    Ikwuezunma, Ashley
    Dutta, Ankhi
    Castellanos, Maria Isabel
    Paek, Hana
    Palazzi, Debra
    Rabin, Karen R.
    Scheurer, Michael E.
    Gramatges, Maria Monica
    BLOOD, 2020, 136
  • [4] A Strategy For Early Diagnosis Of Invasive Mold Infections In Children With Hematologic Malignancies
    Cohn, Shannon Mitchell
    Pokala, Hanumantha R.
    Leonard, David
    Slone, Tamra
    Stegner, Martha M.
    John, McClay
    Winick, Naomi J.
    BLOOD, 2013, 122 (21)
  • [5] Non-Aspergillus invasive mold infections in patients with hematologic diseases: A single center experiences for 6 years
    Lee, H. J.
    Cho, S. Y.
    Lee, D. G.
    MYCOSES, 2017, 60 : 181 - 181
  • [6] Application of a standardized screening protocol for diagnosis of invasive mold infections in children with hematologic malignancies
    Cohn, Shannon M.
    Pokala, Hanumantha R.
    Siegel, Jane D.
    McClay, John E.
    Leonard, David
    Kwon, Jeannie
    Timmons, Charles F.
    Winick, Naomi J.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (12) : 5025 - 5033
  • [7] Application of a standardized screening protocol for diagnosis of invasive mold infections in children with hematologic malignancies
    Shannon M. Cohn
    Hanumantha R. Pokala
    Jane D. Siegel
    John E. McClay
    David Leonard
    Jeannie Kwon
    Charles F. Timmons
    Naomi J. Winick
    Supportive Care in Cancer, 2016, 24 : 5025 - 5033
  • [8] Treatment of invasive fungal infections in patients with hematologic malignancy
    Sanz, MA
    Salavert, M
    Jarque, I
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2002, : 4 - 12
  • [9] Invasive Mold Infections in Patients with Chronic Lymphoproliferative Disorders
    Facchinelli D.
    Marchesini G.
    Nadali G.
    Pagano L.
    Current Fungal Infection Reports, 2018, 12 (4) : 179 - 186
  • [10] Treatment strategies for invasive fungal infections in patients with hematologic malignancies
    Wemeau, Mathieu
    HEMATOLOGIE, 2011, 17 (04): : 271 - 276